News-PR_Al-Aly_cardiac_art_final (IMAGE)

Washington University in St. Louis

News-PR_Al-Aly_cardiac_art_final

Caption

WashU Medicine researchers found that stopping GLP-1 drugs such as semaglutide and tirzepatide — even temporarily — elevates the risk of heart attack, stroke and death compared to staying on the medication continuously.

Credit

Sara Moser and Alaska Adams / WashU Medicine

Usage Restrictions

This image is to be used in accordance with the mission, policies and guidelines of WashU Medicine. Visit https://wustl.edu/about/compliance-policies/media-policies/multimedia-use/ for more information.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.